Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06584929 · ClinicalTrials.gov registry record · NA
Rural Smoking Cessation
A NA study, sponsored by Masonic Cancer Center, University of Minnesota.
- Recruiting
- Registry status
- NA
- Development phase
- 272
- Enrollment target
NCT06584929 is a NA study that is actively recruiting participants, run by Masonic Cancer Center, University of Minnesota. The registered enrollment target is 272 participants.
The verdict
NCT06584929, a NA study, is actively recruiting participants, sponsored by Masonic Cancer Center, University of Minnesota.
- RECRUITING
- Registry status
- NA
- Development phase
- 272 participants
- Enrollment target
Study Summary
Understanding ways to help people who live in rural areas quit smoking is a public health priority. quitting smoking among rural people who smoke is a critical public health concern. People in rural areas smoke at higher rates than those in urban areas, experience high rates of smoking caused cancers and deaths. We are recruiting rural people from around the country to better understand how different quit smoking methods can improve a person's chances of successfully quitting smoking.
Interventions
- DRUG Nicoderm CQ nicotine patch
- DRUG Nicorette Nicotine Lozenges
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 272 participants |
| Start Date | 2026-03-17 |
| Est. Completion | 2029-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06584929
The ClinicalTrials.gov registry entry for NCT06584929 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 272 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Masonic Cancer Center, University of Minnesota, which has 249 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Nicoderm CQ nicotine patch is the first listed.
NCT06584929 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06584929 about?
NCT06584929 is a clinical study titled "Rural Smoking Cessation". Understanding ways to help people who live in rural areas quit smoking is a public health priority. quitting smoking among rural people who smoke is a critical public health concern. People in rural areas smoke at higher rates than those in urban areas, experience high rates of smoking caused cancer...
What is the current status of trial NCT06584929?
This trial is currently recruiting. It is a NA study. The enrollment target is 272 participants. The study started on 2026-03-17. Estimated completion is 2029-08-31.
What interventions are being tested in trial NCT06584929?
The interventions under investigation include: Nicoderm CQ nicotine patch (DRUG), Nicorette Nicotine Lozenges (DRUG).
Who is sponsoring clinical trial NCT06584929?
This trial is sponsored by Masonic Cancer Center, University of Minnesota, which has 249 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.